Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor.

Cell | Mar 7, 2003

Granzyme A (GzmA) induces a caspase-independent cell death pathway characterized by single-stranded DNA nicks and other features of apoptosis. A GzmA-activated DNase (GAAD) is in an ER associated complex containing pp32 and the GzmA substrates SET, HMG-2, and Ape1. We show that GAAD is NM23-H1, a nucleoside diphosphate kinase implicated in suppression of tumor metastasis, and its specific inhibitor (IGAAD) is SET. NM23-H1 binds to SET and is released from inhibition by GzmA cleavage of SET. After GzmA loading or CTL attack, SET and NM23-H1 translocate to the nucleus and SET is degraded, allowing NM23-H1 to nick chromosomal DNA. GzmA-treated cells with silenced NM23-H1 expression are resistant to GzmA-mediated DNA damage and cytolysis, while cells overexpressing NM23-H1 are more sensitive.

Pubmed ID: 12628186 RIS Download

Mesh terms: Active Transport, Cell Nucleus | Apoptosis | Carbon-Oxygen Lyases | Chromosomal Proteins, Non-Histone | DNA Fragmentation | DNA, Single-Stranded | DNA-(Apurinic or Apyrimidinic Site) Lyase | Deoxyribonucleases | Gene Expression Regulation | Gene Silencing | Genes, Tumor Suppressor | Granzymes | HMGB2 Protein | HeLa Cells | Histone Chaperones | Humans | Immunity, Cellular | Jurkat Cells | K562 Cells | Models, Biological | Monomeric GTP-Binding Proteins | NM23 Nucleoside Diphosphate Kinases | Nuclear Proteins | Nucleoside-Diphosphate Kinase | Nucleosomes | Phosphoproteins | Serine Endopeptidases | T-Lymphocytes, Cytotoxic | Transcription Factors

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.